Person:
Porter, Alan L.

Permanent Link
https://hdl.handle.net/1853/71596
Associated Organization(s)
ORCID
ArchiveSpace Name Record

Filters

2018 - 2020 2
1 1
1
2
2
Reset filters

Settings
Author: Kostoff, Ronald N. × Author: Buchtel, Henry A. ×

Publication Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Communicable diseases are not communicable
    (Georgia Institute of Technology, 2020-10) Kostoff, Ronald N. ; Briggs, Michael B. ; Kanduc, Darja ; Porter, Alan L. ; Buchtel, Henry A.
    Communicable disease is a misnomer. The disease is not communicable; the microbe mainly associated with the disease is communicable. Whether the recipient of the microbe develops the disease depends on the health of the recipient’s immune system. Our model of COVID-19 development starts with real-life exposures to multiple toxic stressors degrading the immune system. This is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. To prevent or treat infectious disease, the health of the immune system must be maintained or improved. One major component of maintaining and improving immune system health is removal of those factors that contribute to immune system degradation. A previous monograph identified many factors that contribute to immune system degradation (Contributing Factors (CFs)). It was hypothesized that many of these CFs to immune system degradation were identical to those that past studies have shown were CFs to chronic diseases. To test this hypothesis, a proof-of-principle demonstration was performed to identify the commonality between CFs to immune system degradation and CFs to Parkinson’s Disease (PD). A very streamlined approach was used, and approximately 500 CFs were found in common between the two diseases. Since COVID-19 (and other infectious diseases) results from immune system degradation in our model, this means COVID-19 and PD are enabled by many of the same toxic exposures and toxic behaviors. Thus, many of the measures required to strategically treat and prevent infectious diseases are similar to those required to strategically treat and prevent chronic diseases. This is a major paradigm shift for orthodox Western medicine, but is required to achieve major advances in global population health.
  • Thumbnail Image
    Item
    Prevention and reversal of Alzheimer's disease: treatment protocol
    (Georgia Institute of Technology, 2018-01-23) Kostoff, Ronald N. ; Porter, Alan L. ; Buchtel, Henry A.
    This monograph presents a five-step treatment protocol to prevent and reverse Alzheimer's Disease (AD), based on the following systemic medical principle: at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective. The five treatment protocol steps are as follows: Step 1 - obtain a detailed medical and habit/exposure history from the patient; Step 2 - administer written and clinical performance and behavioral tests to assess the severity of the higher-level symptoms and degradation of executive functions; Step 3 - administer laboratory tests (blood, urine, imaging, etc.); Step 4 - eliminate ongoing AD contributing factors; Step 5 - implement AD treatments. This individually-tailored AD treatment protocol can be implemented with the data available in the biomedical literature presently. Additionally, while the methodology developed for this study was applied to AD, it is general and applicable to any chronic disease that, like AD, has an associated substantial research literature. Thus, the protocol and methodology we have developed to prevent or reverse AD can be used to prevent or reverse any chronic disease (with the possible exceptions of individuals with strong genetic predispositions to the disease in question or who have suffered irreversible damage from the disease).***NOTE***There are four files in this record. Presently, they are located in the left column of this Web page listed under the heading View/Open. MONOGRAPH_FINAL.pdf contains the monograph narrative; FIGURES_FINAL.xlsx contains the figures from the monograph in Excel spreadsheet format; SUPPLEMENTARY_FINAL.pdf contains supplementary bibliography and queries; and README.pdf is the ReadMe file. The two data files are referenced in the monograph as either "(see file FIGURES_FINAL.xlsx)" or "(see file SUPPLEMENTARY_FINAL.pdf)".